Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100048587Phase 4Recruiting
Phase 4, randomised trial of esketamine in Postoperative sleep disturbance (PSD) and postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Postoperative sleep quality, Static VAS pain score and 3 more. Started Oct 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100048587.